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Abstract
Background: The Candida species, which are one of the most common causes of nosocomial bloodstream infections, 
present with high mortality and morbidity rates. This study aims to investigate the production of esterase, phospholipase, 
proteinase, and biofilm formation ability of the Candida strains isolated from the blood cultures.
Materials and Methods: Between June 2011 and July 2012, the Candida strains, which were isolated from blood cultures 
of a total of 50 patients, were studied. The esterase activity was analyzed in the Tween-80 agar, while phospholipase 
activity was studied in the egg yolk agar. The proteinase activity and biofilm formation were identified by using the petri 
dish method and microplate method, respectively.
Results: Of 50 specimens obtained from individual patients, 17 (34%) were identified as C. albicans, 14 (28%) as 
C. glabrata, 9 (18%) as C. parapsilosis, 5 (10%) as C. krusei, 4 (8%) as C. kefyr, and 1 (2%) as C. tropicalis. The rate 
of proteinase, phospholipase, and esterase positivity was higher in the C. albicans isolates. Biofilm formation was the 
highest in the C. parapsilosis strains.
Conclusions: Higher rate of virulence factors in the most commonly isolated Candida species than other species 
indicates that these virulence factors play a crucial role in the pathogenesis.
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Introduction
In the recent years, the incidence of serious fungal 
infections, invasive Candida infections particularly, has been 
increasing due to an increased number of patients receiving 
immunosuppressive therapy, increased major surgeries 
and broad‑spectrum antibiotherapy, hyperalimentation, 
prolonged intensive care unit stay for patients with poor 
health status, and increased use of artificial prostheses.[1,2] 
The Candida species are the fourth most common cause 
of nosocomial bloodstream infections, accounting for 
nearly 10% of all. It follows coagulase‑negative staphylococci, 
Staphylococcus aureus, and enterococci with high morbidity 
and mortality rate.[2‑4] Virulence factors as well as attenuated 
defense mechanism of the host play a critical role in the 
development of these infections. Extra‑cellular hydrolytic 
enzymes of Candida species facilitate adherence and 
tissue penetration, and therefore invasion of the host.[5] 
However, biofilm producing Candida species are known to 
be more resistant to immune response and antimicrobial 
agents, which lead to treatment failure.[6] Although 
there is a growing number of studies reporting virulence 
factors of other strains, C. albicans is the most commonly 
analyzed strain in which several virulence factors including 
phenotypic changes, morphological dimorphism, adhesion 
molecules, hydrolytic enzymes (e.g. phospholipase, lipase, 
and aspartic proteinases), catalase, superoxide dismutase, 
and heat‑shock proteins have been identified.[7,8]
In this study, we aimed to investigate the production of 
esterase, phospholipase, proteinase, and biofilm formation 
ability of the Candida strains isolated from the blood 
cultures.
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Table 1: Esterase, phospholipase, and proteinase activity 




Esterase Proteinase Phospholipase Biofilm
VS S M/W
C. albicans (17) 11 (64.7) 14 (82.4) 5 (29.4) 5 (29.4) 5 (29.4) 1 (5.9)
C. glabrata (14) 1 (7.1) 4 (28.6) 0 (0) 4 (28.6) 1 (7.1) 0 (0)
C. parapsilosis (9) 0 (0) 4 (44.4) 0 (0) 0 (0) 1 (11.1) 7 (77.7)
C. krusei (5) 2 (40) 2 (40) 0 (0) 1 (20) 1 (20) 0 (0)
C. keyfr (4) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
C. tropicalis (1) 1 (100) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Total (50) 15 (30) 24 (48) 5 (10) 10 (20) 8 (16) 8 (16)
VS=Very strong; S=Strong; M/W=Medium/weak; C. albicans=Candida 
albicans; C. glabrata=Candida glabrata; C. parapsilosis=Candida 




Between June 2011 and July 2012, the Candida strains, 
which were isolated from blood cultures of a total of 
50 patients, were studied. The blood samples which were 
sent from various departments of our hospital to the central 
laboratory were incubated in the BacT/Alert 3D Automation 
System (Biomerieux, France). Some preparations were done 
using the blood samples with a hint for bacterial production, 
and those with yeast cells as confirmed by Gram‑staining 
were passaged to the CHROMagar Candida (BBL, France) 
and Sabouraud dextrose agar (Oxoid, UK). The isolates 
were identified by the germ tube test results; morphological 
images obtained from the Tween‑80 corn‑meal agar, and 
API 20C AUX system (Biomeriuex, France).
Investigation of virulence factors
The phospholipase activity was studied in the egg yolk 
agar. 10 µ yeast suspension was added at 0.5 McFarland 
turbidity and incubated at 37°C for 4 days. The ratio of 
colony diameter to the diameter of precipitation zone was 
calculated (precipitation zone; Pz). With respect to the 
phospholipase activity, Pz: ++++ or ≤0.69 = very strong, 
+ + + or 0.70–0.79 = strong, ++ or 0.80–0.89 = medium, 
+ or 0.90–0.99 = weak positive. Pz ≥ 1: Negative.[7,9]
The esterase activity was studied using an agar containing 
1% peptone, 0.5% NaCl, 0.01% CaCl2, and 1.5%/L at 
6.8 pH. When heated at 45–50°C, 5 mL Tween‑80 was 
added. The round‑shaped strains with 10‑mm in diameter 
were incubated at 30°C for 10 days. The presence of a 
transparent halo around the inoculum site indicated 
positivity.[7,10]
The proteinase activity was analyzed by using an agar 
containing 0.1% KH2PO4, 0.05% MgSO4, 2% agar, and 
1% bovine serum albumin per liter at 4.5 pH. 10 µL yeast 
suspension was added and a transparent zone around the 
colony was investigated.[9]
The biofilm formation ability of the isolates was identified 
by using the microplate method. The brain heart infusion 
broth (BHIB; Oxoid, UK) containing 0.25% glucose 
was prepared and put into 2‑mL tubes. A loop full of 
each isolate was added and incubated at 37°C for 24 h. 
Then, each tube was diluted at 1:40 with a fresh BHIB. 
The final solution was seeded into a 96‑well polystyrene 
microplate (Nunc, Denmark) and incubated at 37°C for 
24 h. At the end of the incubation period, it was washed 
with phosphate buffer solution 3 times, inverted, and dried. 
200 µL of crystal violet 1% was added and standard for 
15 min. At the end of the incubation period, it was washed 
3 times, and 200 µL mixture of ethanol‑acetone (80:20 v/v) 
was added to each well. It was studied by the enzyme‑linked 
immunosorbent assay kit (BioTek, ELX 800, USA) at 
450 nm wavelength. The optic density (OD) of the 
well was recorded. A sterile BHIB, which contained no 
microorganism, was identified as a negative control. The 
mean OD of sterile BHIB wells was calculated, and the 
cut‑off value was estimated using + 2 standard deviations. 
The samples which produced OD above the cut‑off value 
were considered as positive, while samples with OD below 
the cut‑off value were considered as negative.[11]
Candida albicans ATCC 90028 was used as a control stain in 
the phospholipase, esterase, and proteinase tests. All tests 
were repeated 3 times for each strain. Statistical analysis 
was performed using SPSS (SPSS Inc., Chicago, IL, USA) 
version 11.5 software. The Chi‑square test was also done. 
P < 0.05 was considered as statistically significant.
Results
A total of 50 patients were included in the study. Then 
median age of the patients was 50 years and 32 (64%) were 
male, and 18 (36%) were female. Most patients were from 
the intensive care units (27/50; 54%), 18/50 (36%) from 
medical wards and 5/50 (10%) from surgical wards. At least 
one underlying medical condition was identified in 47 cases 
of candidemia (94%). The most frequent underlying disease 
in patients with candidemia was cancer (38%), especially 
solid tumors (28%). Lung disease and acute/chronic kidney 
failure were the 2nd and the 3rd most frequent underlying 
disease, respectively (18% and 14%, respectively). Only 
three patients had diabetes (6%).
Of 50 specimens obtained from different patients, 17 (34%) 
were identified as C. albicans, 14 (28%) as C. glabrata, 
9 (18%) as C. parapsilosis, 5 (10%) as C. krusei, 4 (8%) as 
C. kefyr, and 1 (2%) as C. tropicalis. Eleven (64.7%) of the 
C. albicans strains had positive esterase activity, 14 (82.4%) 
had positive proteinase activity, 15 (88.2%) had positive 
phospholipase activity, and 1 (5.9%) had positive biofilm 
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formation. In addition, 1 (7.1%) of the C. glabrata strains had 
positive esterase activity, 4 (28.6%) had positive proteinase 
activity, and 5 (35.7%) had positive phospholipase activity. 
However, biofilm formation was not identified in this strain. 
The rate of proteinase, phospholipase, and esterase positivity 
was statistically higher in the C. albicans isolates than 
non‑albicans Candida isolates (P < 0.001). Biofilm formation 
was the highest in the C. parapsilosis strains, indicating 
statistical significance (P < 0.001). However, no virulence 
factor was identified in the C. kefyr strains [Table 1].
Discussion
In parallel to the increasing number of high‑risk 
immunocompromised patient population, the Candida 
species has become particularly important as one of 
the most common causes of nosocomial bloodstream 
infections.[12] The C. albicans is the most isolated pathogen 
in the Candida species‑associated bloodstream infections, 
followed by C. parapsilosis, C. glabrata, C. krusei, C. tropicalis 
with an increasing incidence.[13,14] Despite varying 
incidence according to the region, C. glabrata and 
C. parapsilosis may be a cause of candidemia.[15,16] In our 
study, C. albicans (34%) is the leading cause of candidemia, 
followed by C. glabrata (28%).
Extra‑cellular hydrolytic enzymes of Candida species 
acting as virulence factors which contribute to host‑tissue 
invasion by digesting proteins (hemoglobin, keratin, 
collagen, etc.)[17] formation of Candida biofilms occurring 
on devices such as indwelling intravascular catheters, 
infections become more refractory to antimicrobial 
agents.[18] Earlier studies demonstrated that C. albicans 
produced extra‑cellular phospholipase alone. However, 
further studies showed that non‑albicans Candida 
produced also phospholipase but at a lesser extent.[19] 
In the present study, we found that 15 (88.2%) of 17 
C. albicans strains and only 8 (24.2%) of 33 non‑albicans 
Candida species (C. glabrata [n = 5], C. krusei [n = 2], 
and C. parapsilosis [n = 1]) had positive phospholipase 
activity. Birinci et al.[20] reported that 42 (67.7%) of 62 
C. albicans strains isolated from the blood samples had 
phospholipase activity. However, the authors reported no 
phospholipase activity in the non‑albicans Candida species. 
Similarly, De Luca et al.[21] showed that 32 (100%) of the 
C. albicans strains and only one of the C. parapsiolosis 
strains had phospholipase activity. Another study revealed 
that 41 of the C. glabrata strains, 50% of the C. parapsilosis 
strains, 70% of the C. tropicalis, 80% of the C. lusitaniae, 
and 10% of the C. krusei had phospholipase activity. The 
authors, however, concluded that relatively low rates 
were associated with small sample size of the Candida 
strains (n = 51).[22] In our study, using a similar sample 
size with the aforementioned study, we found 35.7% of the 
C. glabrata strains, 40% of the C. krusei strains, and 11.1% 
of the C. parapsilosis strains with phospholipase activity.
Furthermore,  we observed that  11 (64.7%) of 
17 C. albicans and 4 (12.1%) of 33 non‑albicans 
Candida (C. glabrata [n = 1], C. krusei [n = 2], and 
C. tropicalis [n = 1]) had esterase activity. Review 
of literature has demonstrated that C. albicans and 
C. tropicalis are the most common strains exerting esterase 
activity.[7,10,23,24] Yücesoy and Marol[23] reported that 95% 
of the C. albicans, 93% of the C. tropicalis, 57% of the 
C. parapsilosis, and 10% of the C. glabrata had esterase 
activity. In addition, Aktas et al.[24] found that 98.3% 
of the C. albicans, and 100% of the C. tropicalis and 
C. guilliermondii had esterase activity. In our study, we 
observed a lower rate of esterase activity in the C. albicans 
strains along with one of the C. tropicalis strains with 
positive activity. We also found esterase activity in 40% of 
the C. krusei and 7.1% of the C. glabrata. However, none 
of the C. parapsilosis and C. keyfr had esterase activity.
Moreover, we reported that 82.4% of the C. albicans and 
30.3% of the non‑albicans Candida had proteinase activity. 
Consistent with our findings, Gokce et al.[17] showed 
proteinase activity in 89.7% of the C. albicans and 25.2% 
of the non‑albicans Candida of the isolated from blood 
cultures. Similarly, Bramono et al.,[25] reported a significantly 
higher rate of proteinase activity in the C. albicans strains, 
followed by the C. parapsilosis C. tropicalis. In our study, the 
C. albicans had the highest proteinase activity, followed by C. 
parapsilosis (44.4%), C. krusei (40%), and C. glabrata (28.6%).
Based on our study results, only 1 (5.9%) of the C. albicans 
and 77.7% (7/9) of the C. parapsilosis strains had the biofilm 
formation ability. On the other hand, Gültekin et al.[7] 
had reported that none of the C. albicans isolates had the 
biofilm formation ability with the highest positivity ratio 
of the C. parapsilosis strains. In addition, Shin et al.[26] also 
showed that the C. parapsilosis had the highest ratio for the 
biofilm formation, followed by the C. albicans. The authors 
concluded that there was a significant difference in the 
biofilm formation ability between the C. parapsilosis strains 
isolated from the blood samples and other samples.
Conclusion
We suggest that inconsistent results of previous studies 
in respect of the phospholipase, proteinase, and esterase 
activity as well as the biofilm formation ability of the Candida 
species can be attributed to the nonstandardized sample 
size including the number of strains, patient characteristics, 
regional variations, and methodological differences. Higher 
rate of virulence factors in the most commonly isolated 
Candida species than other species indicates that these 
virulence factors play a crucial role in the pathogenesis. 
However, further studies in a higher number of strains of 
a limited number of species are required to confirm these 
findings.
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